Brief: Echoiq Ltd Seeks Trading Halt Pending Announcement On U.S. Clinical Study Results.
29/11/2022 24:18
Nov 29 (Reuters) - EchoIQ Ltd EIQ.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON US CLINICAL
STUDY
RESULTS.
Source text for Eikon: urn:newsml:reuters.com:*:nASX37sys9
Further company coverage: EIQ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt